TOP2B and prostate cancer: Although the mechanistic causes and endogenous role of these DSBs in AR signaling are unclear and are the subject of ongoing research, the finding that AR stimulation could lead to TOP2B-mediated DSBs was highly reproducible and robust and presented a potential novel paradigm of exploiting AR signaling to sensitize prostate cancer cells to other therapeutics [8, 10].